Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone

Clinical trial NCT00600756 · COMPLETED

Trial details

NCT number: NCT00600756
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenic Disorders

Start date: 2008-01-01
Primary completion: 2009-10-01
Enrollment: 798

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.